TierPoint, a leading provider of secure, connected IT platform solutions, today announced it has earned the Microsoft Solutions Partner designation for Private Cloud, further reinforcing the company’s ...
Nutanix was positioned closest to VMware in the "Leaders" quadrant, a spot the firm has been nurturing for some time. It has ...
Policy-Driven Cyber Resilience: Cyber resilience is no longer a separate workflow. With R-Shield embedded into HYCU’s Unified Policy Engine, customers can now set RPOs, RTOs, validation, replication, ...
Options Becomes First Financial Sector Provider to Achieve Microsoft Solutions Partner Accreditation for Private Cloud ...
Zacks Investment Research on MSN
Should You Buy, Sell or Hold HPE Stock After a 15.9% Rise in a Month?
Hewlett Packard Enterprise HPE has gained 15.9% in the past month, outperforming the Zacks Computer - Integrated Systems ...
Its IPO of INR 5,603 million is an offer for sale and is aimed at providing liquidity to its promoters and existing ...
Marvell Technology, Inc., a leader in data infrastructure semiconductor solutions, is expanding its partnership with Microsoft, as the company has selected the Marvell LiquidSecurity family of ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
What are the new Azure Latch codes? Becoming the ultimate egoist takes far more than a few fancy tricks, though it doesn't hurt to have Kaiser or Rin's playstyles in your locker. Of course, you'll ...
China’s Victory Day parade drew world attention to a single weapon system that Beijing showcased with pride: the YJ-21, promoted at home as a “killer missile”. Chinese media claims the missile can ...
Products featured in this article are independently selected by This is Money's specialist journalists. If you open an account using links which have an asterisk, This is Money will earn an affiliate ...
Final patient visit marks key milestone for Biofrontera, with top-line results expected Q1 2026 Company plans FDA discussion in Q3 2026 to advance Phase 3 program and potential label expansion More ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback